Catalyst Wire Dossier Catalyst Wire Dossier

Avalglucosidase alfa

avalglucosidase alfa · Genzyme, a Sanofi Company
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Avalglucosidase alfa, covering 2021-04-08 to 2026-04-08. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study for Treatment-naïve IOPD Babies to Evaluate Efficacy and Safety of ERT With Avalglucosidase Alfa [Phase 3]

See pricing